Abstract:SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodelling complexes are potent regulators of cellular differentiation that are encoded by some of the most frequently altered genes in cancer. Within this family, the ATP-dependent (BRG-1/BRM associated factor (BAF) chromatin remodelling complex is altered in roughly 20% of human cancers including gliomas. However, its role in gliomagenesis and progression remains largely unknown. The complex exists in three forms: canonical BAF (BAF), polybromo-associated BAF (PBAF) and a non-canonical BAF cmplex (ncBAF), with specific subunits specifying the distinct complexes. We hypothesize a BAF switch as a driver of glioma proliferation and invasiveness. Analysis of 18 human gliomas specimens revealed that BAF complexes were differentially expressed based on World Health Organization (WHO) grade. Specifically, the expression levels of PBAF components (BRD7 and SMARCB1) decreased significantly as WHO grade increased. Conversely, the canonical BAF complex component SMARCE1, and the ncBAF complex component BRD9 were upregulated in high grade vs low grade gliomas. We used CRISPRi to investigate the role of BAF complex in glioblastoma (GBM) tumorigenesis using control and knockdown murine male and female GBM astrocytes. Growth assays demonstrated distinct sex-dependent effects of the three different BAF complex knockouts on GBM astrocyte proliferation. Depletion of SMARCE1 and SMARCB1 resulted in a significant increase in astrocyte growth in male cells, suggesting a potential inhibitory role of canonical BAF in male GBM astrocyte proliferation. Surprisingly, SMARCE1 knockdown led to markedly decreased cell growth in female cells. Knockdown of BRD9 had no effect on proliferation in either male or female GBM cells, suggesting that BRD-9-containing ncBAF may not play a role in the regulation of gliomagenesis. However, knockdown of BRD7 (PBAF) resulted in marked increase in astrocyte growth in both male and female cells. To investigate the clonogenic capacity of the BAF component depleted cells, we performed extreme limiting dilution analysis (ELDA). There was a significant increase in sphere-forming capacity in BRD7 KD cells in both males and females. There was a significant increase in clonogenic frequency in SMARCE1 and SMARCB1 KD in males only, with a significant decrease in sphere formation in SMARCE1 KD in females. Knockdown of BRD9 showed no effect on sphere forming capacity in mouse GBM cells. This data was consistent with tumor cell growth assays and demonstrated a role of BAF in regulation of clonogenic capacity GBM astrocytes.To define the epitranscriptomic effect of BAF complex depletion in GBM cells, we are conducting ChIP- and RNA-seq for the control and BAF depleted GBM cells and characterizing the effect of subunit depletion on BAF complex assembly and composition using affinity purification and mass spectrometry. Understanding the mechanisms underlying the sex-dependent effects of the BAF chromatin remodelling complex in gliomas could be valuable for the development of new precision therapeutics. Citation Format: Adham Halaoui, Najla Kfoury-Beaumont, Thomas Beaumont. Sex-specific chromatin remodeling drives tumorigenesis in glioblastoma [abstract]. In: Proceedings of the AACR Special Conference on Brain Cancer; 2023 Oct 19-22; Minneapolis, Minnesota. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_1) nr B011.

Abstract B011: Sex-specific chromatin remodeling drives tumorigenesis in glioblastoma

Epco-49. Sex-Specific Chromatin Remodeling Drives Tumorigenesis In Glioblastoma

Epco-47. Sex-Biased Brd4 Activity Drives Tumorigenesis In Glioblastoma

Abstract 3764: Spatially resolved immune landscape revealed sex-biased T-cell infiltration in glioblastoma

Abstract B039: Identification of sex-specific molecular features in glioma transcriptome

Abstract 4734: BRD8-driven EP400 complex hijacks H2AZ to maintain proliferation in glioblastoma

Abstract 2781: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM

Abstract B009: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM

TMET-23. GLIOBLASTOMA EXHIBIT SEX DIFFERENCES IN BRANCHED-CHAIN AMINO ACID METABOLISM

P07.01.B ANDROGEN RECEPTOR SIGNALING MODULATES BOTH TUMOR AND IMMUNE CELLS IN GLIOBLASTOMA AND IMPACTS GLIOBLASTOMA GROWTH

BAF complex maintains glioma stem cells in pediatric H3K27M-glioma

Abstract LB304: Mechanisms of cell death escape in glioblastoma

Epco-27. Chromatin Remodeling Reprograms The Transcription Network In Glioblastoma

Abstract 5666: Exploring spatially resolved intra-tumoral heterogeneity of glioblastoma and neuronal mechanisms facilitating brain invasion

Abstract 3875: Glioblastoma mutational profiles drive cancer cell signaling and immune evasion

Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants

Abstract 427: A molecular signature for the G6PC3/SLC37A2/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype

Abstract 1248: The BRD8/p53 epigenetic switch re-establishes tumor suppression in glioblastoma

Abstract 3750: miR-590-3p inhibits multiple oncogenic nodes within the TGFBR2:SMAD2/3 pathway in recurrent GBM cells

Abstract 5846: Inhibiting elements of the proteasome recovery pathway sensitizes glioblastoma to proteasome inhibitors

Abstract 1243: Shifted mSWI/SNF complex assembly and function underlie therapeutically targetable dependencies in endometrial carcinoma